• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review - Product Image

Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review

  • Published: April 2014
  • 50 pages
  • GlobalData

FEATURED COMPANIES

  • Alpex Pharma SA
  • Cytos Biotechnology AG
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.
  • Mymetics Corporation
  • Novartis AG
  • MORE

Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list READ MORE >

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Actelion Ltd - Key Facts
Actelion Ltd - Key Employees
Actelion Ltd - Key Employee Biographies
Actelion Ltd - Major Products and Services
Actelion Ltd - Pharmaceutical Pipeline Products Data
Actelion Ltd, Pipeline Products by Therapy Area
Actelion Ltd, Pipeline Products by Development Phase
Actelion Ltd - History
Actelion Ltd - Company Statement
Actelion Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Actelion Ltd - Business Description
Actelion Ltd - SWOT Analysis
SWOT Analysis - Overview
Actelion Ltd - Strengths
Strength - Marketed Products
Strength - Widespread Geographic Reach
Strength - Focused R&D Activities
Strength - Increase in Profitability
Actelion Ltd - Weaknesses
Weakness - Legal Proceedings
Actelion Ltd - Opportunities
Opportunity - Market Potential: PAH
Opportunity - Changing Demographics
Opportunity - New Developments
Opportunity - Products Pipeline
Actelion Ltd - Threats
Threat - Growing Parallel Trade
Threat - Uncertain R&D Outcomes
Threat - Cost Containment Pressures
Actelion Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Actelion Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Actelion Ltd, Recent Developments
Oct 10, 2013: Actelion to discuss nine months 2013 financial results
Aug 27, 2013: Actelion appoints André C. Muller as new Chief Financial Officer and member of Actelion's Executive Committee
Jul 18, 2013: Actelion delivers strong progress in the first half of 2013
Apr 18, 2013: Actelion's Annual General Meeting of Shareholders held in Basel, Switzerland
Apr 16, 2013: Actelion Reports Revenue Of CHF432.8m In Q1 2013
Mar 14, 2013: Actelion nominates Mr. John J. Greisch for election to the Board of Directors
Feb 14, 2013: Actelion Reports Revenue Of CHF1.7 Billion In 2012
Jan 07, 2013: Actelion to present at the 31st Annual J.P. Morgan Healthcare Conference - Delivering on our strategy
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Actelion Ltd, Key Facts
Actelion Ltd, Key Employees
Actelion Ltd, Key Employee Biographies
Actelion Ltd, Major Products and Services
Actelion Ltd, Number of Pipeline Products by Therapy Area
Actelion Ltd, Number of Pipeline Products by Development Stage
Actelion Ltd, Pipeline Products By Therapy Area and Development Phase
Actelion Ltd, History
Actelion Ltd, Subsidiaries
Actelion Ltd, Key Competitors
Actelion Ltd, Ratios based on current share price
Actelion Ltd, Annual Ratios
Actelion Ltd, Interim Ratios
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Actelion Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Actelion Ltd, Pipeline Products by Therapy Area
Actelion Ltd, Pipeline Products by Development Phase
Actelion Ltd, Performance Chart (2009 - 2013)
Actelion Ltd, Ratio Charts
Actelion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Actelion Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014

Santhera Pharmaceuticals Holding AG
Novartis AG
Mymetics Corporation
Merck Serono S.A.
F. Hoffmann-La Roche Ltd.
Alpex Pharma SA
Cytos Biotechnology AG
Anavex Life Sciences Corp.

Note: Product cover images may vary from those shown

RELATED PRODUCTS